Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Drs. Steven Krakora and Brandon Humberger Offer Complimentary Virtual Consultations for Dental Implants and Cosmetic Dentistry in Steubenville, OH


Drs. Steven Krakora and Brandon Humberger, Oral Surgeons in Steubenville, OH

Drs. Steven Krakora and Brandon Humberger Offer Complimentary Virtual Consultations

Our patients can have incredible outcomes with teeth that are better than they had before.

Patients can now receive complimentary virtual consultations with the oral and maxillofacial surgeons at Western Pennsylvania & Ohio Valley Oral & Maxillofacial Surgery from the comfort and convenience of their own home. Virtual consultations allow the doctors to review a patient’s condition and respond with general treatment plans, expectations and pricing options. After these virtual consultations, patients can schedule in-person appointments for dental implants, wisdom tooth extractions, or other oral surgery appointments at the Steubenville, OH or Washington, PA practice locations.

“Our patients can have incredible outcomes with teeth that are better than they had before,” says oral and maxillofacial surgeon, Dr. Steven Krakora, about replacing missing teeth with dental implants. “We inform patients about the process, about bone grafting and about dental implants, so we can help patients heal and find a better quality of life.”

Even if treatment is highly necessary, for many patients, finding the time to schedule an in-office appointment can be challenging, especially if they’re from out of town. To help these busy patients get their questions answered and learn about their options, Dr. Krakora and Dr. Brandon Humberger are offering complimentary virtual consultations that can be completed anywhere. Patients simply have to visit http://www.westernpaoms.com and upload a picture of their smile or their current x-rays and tell the oral surgeons what they want their dream smile to look like. The doctors will review the images and respond with treatment options, what they can expect and financing options to make the treatments more affordable. With this knowledge, patients can then book in-person appointments to receive the care they need.

Oral and maxillofacial surgery can include both cosmetic and functional treatments. For those missing teeth or who have failing or damaged teeth, dental implants can be used to restore both function and appearance to the smile. Dental implants mimic the function of natural teeth, stimulating the jawbone and allowing patients to chew and eat properly, but they also look natural within the smile. Oral and maxillofacial surgeons also specialize in wisdom teeth extraction, an often-complex surgery that involves removing impacted teeth in hard-to-reach areas of the mouth. For purely cosmetic treatments, patients who have experienced facial trauma or who are dissatisfied with their facial appearance can improve the aesthetics of their face through facial trauma treatment, jaw surgery, soft tissue treatments or BOTOX®.

Patients in need of dental implants or other advanced surgical care can now receive an expert’s opinion from the comfort of their own home. Patients can request a complimentary virtual consultation in Steubenville, OH and Washington, PA by visiting the website http://www.westernpaoms.com. In-person appointments can also be made by calling the offices at 724-223-0579 for the Washington location or 740-264-5300 for the Steubenville location.

About the Oral Surgeons

Western Pennsylvania & Ohio Valley Oral & Maxillofacial Surgery restore smiles and lives of patients in Washington, PA and Steubenville, OH. With over 15 years of experience, board-certified oral and maxillofacial surgeon, Dr. Steven Krakora, is the head of Oral and Maxillofacial Surgery at Washington Hospital. He is a member of many prestigious organizations, including the American Association of Oral and Maxillofacial Surgeons, the American Dental Association, and the Pennsylvania Dental Association, and he has been published in major medical journals. Dr. Brandon Humberger received his Doctor of Dental Medicine degree from the University of Pittsburgh, where he received the American Association of Oral and Maxillofacial Surgery Radiology Award. He is now a Clinical Assistant Professor of Oral & Maxillofacial Surgery at the University of Pittsburgh. The staff at Western Pennsylvania & Ohio Valley Oral & Maxillofacial Surgery is dedicated to changing lives by changing smiles, and prides themselves on ensuring that patients receive constant care throughout every stage of their treatment. The practice has offices in two locations, with one in Washington, PA and one in Steubenville, OH. To learn more about Drs. Krakora and Humberger and the services they offer, visit http://www.westernpaoms.com, or call 724-223-0579 for the Washington, PA office or 740-264-5300 for the Steubenville, OH office.

Share article on social media or email:

Colon Cancer Diagnosis and Treatment Discussed On “Behind The Scenes” With Laurence Fishburne


News Image

The upcoming episode of “Behind The Scenes” will further explain these treatments for colon cancer and the process taken to diagnose individuals.

Multiple Emmy Award-winning actor Laurence Fishburne is the host of the educational show “Behind The Scenes” with Laurence Fishburne. The TV program informs its viewing audience about a wide array of subjects impacting people all across the globe. Coming to the show is an episode featuring the medical field. The show will interview industry professionals as they discuss the diagnosis process and treatment of colon cancer.

In the U.S., colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer death. The lifetime possibility of developing the disease is 4.5% but varies depending on an individual’s family history, lifestyle, etc. Detecting colon cancer at an early stage provides the most considerable chance for a cure.

Proper diagnosis of colon cancer begins as soon as an individual indicates signs and symptoms. Doctors use a scope to examine the inside of the colon as well as blood tests. Once the exact stage of the cancer is determined, a medical professional can administer treatments. Early-stage colon cancer may include minimally invasive surgery, removing polyps, and endoscopic mucosal resection. More advanced colon cancer may involve lymph node removal, a partial colectomy, or surgery to create a way for waste to exit the body as treatment. Further advanced colon cancer treatment could include radiation therapy, chemotherapy, or targeted drug therapy.

Cancer affects a significant number of people all over the world. Not only are those diagnosed with the diseased impacted, but also are the surrounding loved ones. The upcoming episode of “Behind The Scenes” will further explain these treatments for colon cancer and the process taken to diagnose individuals.

“Behind The Scenes” with Laurence Fishburne is a carefully reviewed educational television program. The show has received several awards for its efforts in public TV.

Share article on social media or email:

Impact Advisors Named Best in KLAS No. 1 HIT Implementation Leadership


It is a tremendous honor to be recognized by KLAS, as it represents the collective voice of our clients. We are incredibly grateful for their ongoing support.

Impact Advisors, a leading provider of clinical, revenue cycle and information technology services to the healthcare industry, announced today that it has been named No. 1 Best in KLAS in HIT Implementation Leadership (Large) in the 2020 Best in KLAS: Software and Services report. This recognition makes it the 13th consecutive year the firm has been recognized as Best in KLAS, with awards in a variety of services.

“At Impact Advisors, our primary mission is to empower our clients by providing a broad range of services and solutions with exceptional quality and value,” said Peter Smith, CEO and Co-Founder of Impact Advisors. “It is a tremendous honor to be recognized by KLAS, as it represents the collective voice of our clients. We are incredibly grateful for their ongoing support.”

The Best in KLAS designation is reserved for vendor solutions that lead those software and services market segments that have the broadest operational and clinical impact on healthcare organizations. These vendors earn the title of Best in KLAS – a recognition of their outstanding efforts to help healthcare professionals deliver better patient care. During the preparation of the annual Best in KLAS report, KLAS reviews more than 30,000 interviews conducted with health systems and payers that year.

The Best in KLAS HIT Implementation Leadership (Large) designation is reserved for vendors that provide outstanding efforts to help healthcare organizations deliver quality patient care. Impact Advisors scored a 93.9 in this category.

“Clinical and revenue cycle implementation projects are still a large part of our business and are services our clients continue to need expertise for,” said Andy Smith, President and Co-Founder of Impact Advisors. “It is our goal to partner with clients to understand their current environment and business objectives, define tangible project outcomes, and execute to meet those outcomes. This recognition is validation that we are living up to those expectations.”

“Providers and payers demand better performance, usability, and interoperability from their vendor partners every year. Best in KLAS winners set the standard of excellence in their market segment,” KLAS President Adam Gale said. “Earning a Best in KLAS award should both excite and humble the recipients. It serves as a signal to providers that they should expect only the best from the winning vendors.”

Impact Advisors will attend the Best in KLAS Awards Ceremony on March 9 in Orlando where they will be honored for their excellence.

About Impact Advisors

Impact Advisors is a nationally recognized healthcare consulting firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, technology implementation and performance improvement services. Our comprehensive suite of digital health, clinical optimization and revenue cycle services spans the lifecycle of our clients’ needs. Our experienced team has a powerful combination of clinical, revenue, operations, consulting and IT experience. The firm has earned a number of prestigious industry and workplace awards, including Best in KLAS® for 13 consecutive years, Healthcare Informatics HCI 100, Crain’s Chicago Business Fast Fifty, as well as “best place to work” awards from: Modern Healthcare, Consulting Magazine, Becker’s Hospital Review and Achievers. For more information about Impact Advisors, visit http://www.impact-advisors.com.

About KLAS

KLAS is a data-driven company on a mission to improve the world’s healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit KLASresearch.com.

Share article on social media or email:

Tampa CBD Manufacturer Among First Certified by Florida Department of Agriculture & Consumer Services


Proleve

“Proleve has taken a leadership role in ensuring our products are of the highest standards, and we are proud to be one of the first to receive state certification.”

Proleve Distribution LLC, a Tampa-based CBD Manufacturer, is among the first companies to be officially licensed and certified by Florida’s Department of Agriculture and Consumer Services (FDACS) under new rules that went into effect in January. Receiving this permit means Proleve is a state-approved source for food products containing the hemp extract CBD.

“We at Proleve believe this new regulatory environment will be safer for consumers and will provide them with greater confidence in the CBD products they are purchasing,” said Jonathan Solomon, president of Proleve. “Proleve has taken a leadership role in ensuring our products are of the highest standards, and we are proud to be one of the first to receive state certification.”

FDACS Commissioner Nikki Fried announced the new regulations on January 6 and said that state inspectors would begin enforcement. According to the new regulations (Florida Administrative Code 5K-4.034), any ingested food product sold in the state must come from an approved source that is licensed. Additionally, upon request from any state agency or law enforcement official, anyone selling Hemp Extract or CBD products must provide documentation that they obtain their product from an approved source.

CBD (Cannabidiol) is a non-intoxicating product of the cannabis plant, which has become increasingly popular among consumers. It can be ingested with food or applied topically to the body. The therapeutic benefits of CDB are being tested and evaluated by the U.S. Food and Drug Administration.

“As the CBD market continues to grow quickly across the United States it is vital that consumers have access to quality products that are safe and regulated,” said Solomon. “Florida has taken the necessary steps to regulate and encourage responsible growth of the CBD market by providing pathways for manufacturers like Proleve to become licensed.

“We greatly appreciate all the work FDACS has done with us during our certification process and for guiding the industry. Through these joint efforts CBD consumers in Florida now have the opportunity to use licensed quality products.”

Proleve Distribution LLC is a Florida registered company located in Tampa, FL. http://www.proleve.com.

Share article on social media or email:

New State-of-the-Art Arizona Pain Center Opened February 3, 2020


Dr. Ahdev Kuppusamy, M.D.

Dr. Ahdev Kuppusamy, M.D.

I believe the best part of my profession is knowing that when we help people struggling with pain, we are also improving the lives of everyone around them.

Dr. Ahdev Kuppusamy, M.D. is pleased to announce the opening of The Pain Experts of Arizona. The new, state-of-the-art office is located at 3370 South Mercy Road, Suite 321 in Gilbert, Arizona. Dr. Kuppusamy is a double board certified anesthesiologist and interventional pain specialist whose primary goal is to improve the quality of life of his patients and their families. Call (480) 550-9393 for more information and scheduling.

Dr. Kuppusamy has expertise in all the areas of pain management. He performed his anesthesiology residency and pain medicine fellowship at Robert Wood Johnson University Hospital in New Jersey. His training placed a strong emphasis on mastering the latest, cutting edge techniques to provide the most wide-ranging treatment options for patients.

Recognized as one of Arizona’s top pain doctors, Dr. Kuppusamy provides treatment options including epidural steroid injections, radiofrequency ablation, stem cell therapy, neuromodulation and much more. Dr. Kuppusamy is proficient in the treatment of all pain conditions including back and neck pain, CRPS, scoliosis, migraines, neuropathy, spinal stenosis, pelvic/abdominal pain, and arthritis just to name a few. To provide the most comprehensive treatment available, the doctor prioritizes a multi-disciplinary approach.

Dr. Kuppusamy believes in a down-to-earth approach to medicine and places the highest emphasis on the doctor-patient relationship. His primary focus is placing his patients’ needs first and treating them with the same respect, compassion and care with which he would treat his own friends and family members.

Most insurance plans are accepted at The Pain Experts of Arizona. A full listing is available on the website. Call (480) 550-9393 for more information and to schedule an appointment with Dr. Kuppusamy.

About The Company: The Pain Experts of Arizona was founded with one goal. We want to get our patients back to pain free living through accurate diagnosis and the best treatments available. We bring the highest level of care in a state-of-the-art setting that emphasizes our belief of treating our patients with the same respect, compassion and dedication we would treat our own friends and family. The office is located at 3370 South Mercy Road, Suite 321 in Gilbert, Arizona. Contact us at (480) 550-9393, or info@thepainexpertsofarizona.com, or online at thepainexpertsofarizona.com.

Share article on social media or email:

Applying Data Analytics and a Decentralized Trial Platform for More Efficient Patient-Centric Trials, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

The webinar will focus on the use of real-world data to help sponsors design more patient-centric study protocols that are optimized to patients’ needs and reduce the burden of participation.

Finding the right patients and the right clinical trial sites can be a challenge for any clinical trial. Coupled with the competition for qualified and available sites within a specific therapeutic area, drug development sponsors may also face a shortage of qualified patients to study.

On Tuesday, February 25, 2020 at 11:00am CST/China (12:00pm JST/Japan, 12:00pm KST/Korea), join Covance’s Michelle Jones, MSc, Senior Director of Clinical Informatics and Bireshwar Saha, M.Pharm, Senior Director and Global Head of Clinical Programming & Analytics in a live webinar to learn what sponsors can do to optimize their trials.

The webinar will focus on the use of real-world data to help sponsors design more patient-centric study protocols that are optimized to patients’ needs and reduce the burden of participation. Patient data can also help sponsors pinpoint new geographical locations of patient populations and match those patients to qualified sites by looking beyond historical performance and accounting for disease incidence and protocol-evaluable patient density information. Taken together, these data can increase the predictability of recruitment timelines — a key factor in improving the overall efficiency of a trial.

Additionally, the webinar will cover different study designs such as decentralized hybrid/virtual trials to enable patient-centric drug development.

This webinar will be suitable for senior level directors and managers working in clinical operations, business or clinical development, procurement and other related departments.

For more information or to register for this event, visit Applying Data Analytics and a Decentralized Trial Platform for More Efficient Patient-Centric Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Share article on social media or email:

BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend


BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, announced today it has raised $22 million in Series B financing, launched its new AI-Assisted Reagent Selection product, and expanded its contract with Novartis in a market worth more than $10.2 billion per year in life science R&D cost-saving opportunities.

F-Prime Capital led the round, with participation from Northleaf Capital Partners and existing investors including Gradient Ventures, Inovia Capital, Golden Ventures, and Real Ventures. BenchSci will use the funds to further develop its suite of products that increase the speed and quality of life-saving research by empowering scientists to run more successful experiments, which are the lifeblood of pharmaceutical R&D. As part of the deal, Shervin Ghaemmaghami, Senior Vice President of F-Prime, will join the board of directors.

“BenchSci has assembled an incredibly talented team at the intersection of machine learning and biomedical research. They’re having a real impact at some of the world’s leading pharma companies. We’re thrilled to lead the round and excited by the path ahead,” says Ghaemmaghami.

BenchSci leverages machine learning to target inefficiencies and unnecessary spend in preclinical research. Approximately half of preclinical research is irreproducible, draining $28.2 billion of R&D spend in the US alone each year, with reagents and reference materials accounting for over 36%.(1) This presents life science companies with a $10.2 billion per year opportunity for savings on reagents alone.

BenchSci’s machine learning unlocks this opportunity by evaluating published experiments to identify which reagents will work for which experiments. BenchSci’s first product, AI-Assisted Antibody Selection, focused only on antibodies, one of the most common research reagents. The company’s new AI-Assisted Reagent Selection product expands to other important reagents, including antibodies, recombinant proteins, RNAi, CRISPR, cell lines, and more.

“The pharmaceutical industry is facing a productivity crisis. R&D costs per drug keep rising while revenue is stagnant. Without major change, this crisis will affect everyone. Low or negative returns will reduce investment in new drugs,” says Liran Belenzon, BenchSci CEO and co-founder. “Artificial intelligence promises to reverse the trend. But most AI in drug discovery is unproven. BenchSci’s products, on the other hand, have immediate, quantifiable impact.”

Since commercializing its AI-Assisted Antibody Selection product 18 months ago, BenchSci has proven to decrease costs and accelerate research in 15 of the top 20 pharmaceutical companies and more than 3,600 academic labs. As one of the earliest pharmaceutical companies to benefit from AI-Assisted Antibody Selection, Novartis will also be the first BenchSci customer to deploy the new AI-Assisted Reagent Selection product.

To date, BenchSci has raised $45 million. Its Series B follows a successful Series A led by Inovia Capital, with participation from Gradient Ventures, Google’s AI fund. BenchSci is F-Prime Capital’s first tech investment in Canada, as was Gradient’s Series A investment.

ABOUT BENCHSCI

BenchSci exponentially increases the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by Google’s AI fund, Gradient Ventures, BenchSci uses machine learning to diagnose pharmaceutical R&D health from hidden patterns in procurement data. Customers receive a report on failure rates, productivity, and redundancy by department, therapeutic area, geography, and cost center. They can then address inefficiencies by deploying BenchSci’s AI-Assisted Reagent Selection, which empowers scientists to select the best reagents and design criteria for their experiments. Thereafter, post-deployment reports confirm impact and ROI. A turnkey application of AI with immediate, quantifiable impact, BenchSci now optimizes reagent procurement and experimental success in 15 of the top 20 pharmaceutical companies and over 3,600 leading academic centers globally. Learn more at http://www.benchsci.com.

ABOUT F-PRIME CAPITAL

F-Prime Capital is a global venture capital firm investing in life sciences, healthcare, and technology. Since 1969, F-Prime has worked closely with entrepreneurs and academics to create innovative solutions to some of the world’s most significant challenges in healthcare and technology. For more information, please visit http://www.fprimecapital.com.

rkohl@fprimecapital.com

REFERENCES

1. Freedman LP, Cockburn IM, Simcoe TS (2015) The Economics of Reproducibility in Preclinical Research. PLoS Biol 13(6): e1002165. https://doi.org/10.1371/journal.pbio.1002165

Share article on social media or email:

Founded by cbdMD, Second Annual National Hemp Day Celebrates Continued Growth


News Image

cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), and the Registrar at National Day Calendar, celebrate the second annual “National Hemp Day.”

cbdMD founded the holiday on Feb. 4, 2019, to increase overall awareness and coverage of the entire hemp industry. Due to the passing of the 2018 Farm Bill, hemp-based products – such as CBD oil, plastics, paint, insulation, and biofuels – are more readily available for consumer use than ever before. Thanks to the recent support surrounding the industry, several studies project that the hemp and CBD markets could become a multibillion-dollar industry in just a few short years.

“Celebrating another holiday we founded here at cbdMD is a tremendous honor,” said Ken Cohn, Chief Marketing Officer at cbdMD. “We’re hoping that people will continue to educate themselves on the hemp industry, while continuing to explore the many CBD applications and how they can support an overall outlook on daily well-being.”

National Hemp Day, in conjunction with National CBD Day (August 8), National CBD Month (January), and National Hemp Month (July), was initiated to create awareness while highlighting the many applications of hemp-derived CBD and how it can support millions of people across the world every year. Visit http://www.cbdMD.com to learn more.

About cbdMD

cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA, Life Time, Inc., and Supercross, and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, THC-free* CBD products, please visit http://www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 4,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, including, but not limited to, our ability to expand the sales of our CBD products through our partnerships, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the Securities and Exchange Commission (the “SEC”) on December 18, 2019 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

*THC-free means undetectable at the lowest level which can be consistently detected using valid scientific analytical tools.

Share article on social media or email:

Windstar Cruises Announces Transformative New Spa Concept That Takes Wellness and Travel to New Levels


An updated spa treatment room aboard Wind Surf

“Now with the unveiling of World Spa by Windstar, our guests will be able to take wellness to a deeper level and partake in destination-inspired treatments with locally sourced ingredients, ” says Peter Tobler, Director of Hotel Operations for Windstar Cruises.

With Windstar’s launch of its new World Spa by Windstar, the leading small ship cruise line is taking wellness to new places. Windstar Cruises, which operates six small ships sailing to 80 countries around the globe, features regional spa treatments and destination-themed therapies to enhance guests’ travel experience.

World Spa by Windstar debuted first on Wind Surf which emerged from a major renovation in December 2019. The spa will be included on the three all-suite Star Class ships—Star Breeze, Star Legend and Star Pride—as part of the $250 Million Star Plus Initiative. The three reimagined ships will debut in May, September and December 2020. The look of these new spaces will be calm and serene, providing the perfect backdrop for a transformative experience.

“We’re delighted to expand upon Windstar’s partnership with One Spa World,” says Peter Tobler, Director of Hotel Operations for Windstar Cruises. “Now with the unveiling of World Spa by Windstar, our guests will be able to take wellness to a deeper level and partake in destination-inspired treatments with locally sourced ingredients.”

Travel on its own is a kind of therapy, but with the introduction of its innovative line of destination-themed treatments, the World Spa by Windstar will offer guests an even more profound sense of place. Natural elements are sourced from Windstar’s global destinations for use by spa therapists in a collection of Wanderlust treatments that will vary by region.

The Northern Lights Manicure and Pedicure, which is inspired by the aurora borealis itself includes a soak using seaweed sourced from the Baltic Sea, and warm LED lights modeled after the color-streaked midnight sky helps lessen signs of aging and improves the texture of the skin while also creating an unforgettable light show. A Remineralizing Glacial Mud Body Wrap from Alaska incorporates mud minerals and botanical extracts harvested directly from the remote waters of the Copper River in the Last Frontier. This wrap uses some of the purest ingredients found anywhere on the planet and will rid the skin of impurities while stimulating healthy cell regeneration. A Rosemary and Thyme Massage from the Mediterranean, which uses some of Italy’s most intoxicating ingredients—honey, rosemary and wine—conditions and calms. Additional regional treatments from Asia, Caribbean, Iceland and the South Pacific are on the menu.

In addition to therapies from some of the richest cultures on earth, World Spa by Windstar will introduce guests to a number of other wellness adventures. A range of facial therapies will fuse technology and high-level ingredients to transform skin on a cellular level. From an Aroma Stone Therapy to an Intensely Cleansing Salt Scrub, massages and body treatments employ the world’s best ingredients and techniques, while kneading out stress and restoring inner peace. The World Spa is also bringing ancient healing remedies from the Far East to the high seas, including acupuncture and traditional Chinese medicine.

Massage therapists and beauticians will be using products from Elemis, the luxurious British body and skincare line. And in keeping with Windstar’s dedication to providing the best in class in all areas, guests will now have access to a true spa and fitness center, with new and improved gym equipment from Technogym, an Italian company known for its cutting-edge designs.

In an effort to enliven both mind and body, World Spa by Windstar will also tap into fitness and nutrition to further empower guests’ journeys. Onboard fitness experts can design a custom program to help passengers achieve their wellness goals, using body composition analysis, nutritional consultation based on the prize-winning research of Dr. Barry Sears and scientifically backed personal training. Also offered are Body Sculpt Boot Camp, Pure-Form Pilates, Yoga and more.

To learn more about World Spa by Windstar and authentic small ship cruising, contact a travel advisor or Windstar Cruises by phone at 800-258-7245, or visit http://www.windstarcruises.com.

###

Editor’s note: for spa renderings and menus: https://windstarcruises.webdamdb.com/bp/#/folder/7162195/

Media Contacts: Sarah Scoltock, Windstar PR Director, sarah.scoltock@windstarcruises.com

Sally Spaulding, Percepture Account Director, sspaulding@percepture.com

About Windstar Cruises

Windstar Cruises operates a six-ship fleet of masted sailing ships and all-suite motor ships that cruise with 350 guests or fewer throughout Europe, the Caribbean, Costa Rica and the Panama Canal, Asia, Alaska and British Columbia, Canada and New England, Tahiti and the South Pacific, Mexico and U.S. Coastal, and new for 2020-21, cruises to Australia and New Zealand, Fiji, New Caledonia, Tonga and the Cook Islands. Windstar Cruises is a part of Xanterra Travel Collection.

Share article on social media or email:

Kingstar Media Launched and Nurtures Major Success for Navage


Kingstar Media

“We are proud of the work we have done strategically introducing Navage in the unique market of Canada,” said Ed Crain, President of Kingstar Media. “We are one of the few marketing agencies that has the talent, bandwidth and contacts to use the brand’s success to make a bigger splash in the U.S.”

Performance marketing agency Kingstar Media announced today that its TV campaigns for Navage Nasal Care, a leading manufacturer and distributor of saline nasal irrigation products, has helped the latter’s business grow three-fold since launching in 2014.

Kingstar developed and built Navage’s initial TV campaign in Canada, and helped the product grow via marketing and advertising efforts, and eventually shepherded the brand into the US market. Kingstar has a long, successful history using TV to launch products. Given Kingstar’s history of launching new products in Canada, Navage felt confident trusting the agency to execute the brand’s first paid media campaign.

Navage is now a category leader in volume and sales in the nasal products industry. It has manufactured more than 50,000,000 SaltPod® capsules per year and late last year sold its one millionth nose cleaner.

“We are proud of the work we have done strategically introducing Navage in the unique market of Canada,” said Ed Crain, Founder and President of Kingstar Direct, one of North America’s leading performance-driven video production companies, and Kingstar Media. “Once established there, we are one of the few marketing agencies that also has the talent, bandwidth and contacts to utilize the brand’s success to make a bigger splash in the larger U.S. market.”

“When we decided that Canada would be our global launch site for Naväge Nasal Care, we undertook a diligence process to identify the best Canadian DRTV media buyer, and Kingstar consistently came up number one,” said Martin R. Hoke, President, RhinoSystems, Inc. “We hired them and they did not disappoint! They’ve got a great team led by Anat Freed who is one of the most diligent, insightful, and hardest working Media Managers I’ve ever met. She and her team have consistently demonstrated an exceptional commitment to fighting for – and delivering – the greatest possible media value for us, something that’s incredibly important for a new product launch.”

Retailers in Canada that have successfully marketed Navage products since the category was started in 2014 include:

o    Loblaws

o    Amazon

o    Real Canadian Superstore

o    Bed Bath Beyond

o    London Drugs

o    Jean Coutu

o    Safeway

o    Showcase

About Kingstar Direct and Kingstar Media

Kingstar Direct is one of North America’s leading performance-driven video production companies. Founded by Ed Crain nearly 20 years ago, Kingstar is a video production and marketing agency that anticipates and responds to industry shifts and continually provides true, measurable value to clients. Lending his extensive experience in direct marketing and television production and responding to the new ways in which consumers interact and connect, Crain is driving the agency into the new world of surround sound marketing via Kingstar Media: helping clients communicate across all channels with one voice. Whether building brands, selling direct to consumers, or using direct response as a way to drive web traffic or retail sales, Kingstar has redefined direct response and how it can drive marketing strategy.

About RhinoSystems, Inc.

RhinoSystems, Inc. (RSI) is the company that was created to develop and distribute Naväge® Nasal Care. Founded in 2007, RSI has been granted over 75 issued patents worldwide and numerous trademarks. RSI is headquartered in Brooklyn, Ohio.

RhinoSystems is committed to maintaining the highest quality standards so that our products meet the needs of our customers and the expectations of our stakeholders. RSI is certified to ISO 13485:2016, the internationally recognized standard for medical device manufacturing.

https://www.navage.ca    

Share article on social media or email: